Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
GlaxoSmithKline PLC
OTC:GLAXF
GlaxoSmithKline PLC
OTC:GLAXF
Price:
23.25
USD
-3.13%
Market Closed
Market Cap:
$94.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
GlaxoSmithKline PLC
OTC:GLAXF
|
UK |
|
C
|
Calbee Inc
F:9CB
|
JP |
|
A
|
Avery Dennison Corp
SWB:AV3
|
US |
|
E
|
Enel SpA
XHAN:ENL
|
IT |
|
P
|
Persimmon PLC
XMUN:OHP
|
UK |
|
M
|
Mercedes-Benz Group AG
XMUN:MBG
|
DE |
|
C
|
Canadian Tire Corporation Ltd
OTC:CDNAF
|
CA |
|
C
|
Community Health Systems Inc
F:CG5
|
US |
|
Komercni Banka as
F:KONN
|
CZ |
|
Quantum Computing Inc
NASDAQ:QUBT
|
US |
|
Yankuang Energy Group Co Ltd
OTC:YZCHF
|
CN |
|
L
|
Lands' End Inc
SWB:LED
|
US |
|
H
|
HCA Healthcare Inc
XMUN:2BH
|
US |
|
Biogen Inc
NASDAQ:BIIB
|
US |
|
First Commonwealth Financial Corp
NYSE:FCF
|
US |
|
M
|
Myer Holdings Ltd
SWB:30M
|
AU |
|
C
|
CTT - Correios de Portugal SA
ELI:CTT
|
PT |
|
D
|
Douglas Dynamics Inc
F:5D4
|
US |
|
E
|
Energy Development Company Ltd
NSE:ENERGYDEV
|
IN |
|
G
|
Garmin Ltd
DUS:GEY
|
CH |
|
H
|
Hermes International SCA
DUS:HMI
|
FR |
|
A
|
Applied Materials Inc
F:AP2
|
US |
|
Curaleaf Holdings Inc
TSX:CURA
|
US |
|
G
|
Groep Brussel Lambert NV
OTC:GBLBF
|
BE |
Wall St Price Targets
GLAXF Price Forecast
Based on 27 analysts
Based on 27 analysts
+20% Upside
from
$23.25
today
GlaxoSmithKline PLC (GLAXF)’s 12-month stock price forecast through October 2027 has a consensus target of $27.99, implying 20% upside. The forecast is based on price targets from 27 Wall Street analysts.
GLAXF Analyst Rating
No ratings yet
No ratings yet
GlaxoSmithKline PLC Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GLAXF's stock price target?
Price Target
27.99
USD
27.99
USD
According to Wall Street analysts, the average 1-year price target for GLAXF is 27.99 USD with a low forecast of 19.2 USD and a high forecast of 41.29 USD.
What is the Revenue forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Gross Profit forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for GlaxoSmithKline PLC?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 4%.
What is the Pre-Tax Income forecast for GlaxoSmithKline PLC?
Projected CAGR
13%
13%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 13%.
What is the Net Income forecast for GlaxoSmithKline PLC?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 6%.